Drug Database
Back to search

Poland· PL-100315982

Jardiance

A empagliflozin product containing empagliflozinum, registered in Poland by Boehringer Ingelheim International GmbH. The same ATC class is registered in 16 of our 19 countries.

ATC A10BK03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedJardianceATCA10BK03REGISTER NO.PL-100315982PACKS LISTED9CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about empagliflozinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Empagliflozin is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BK03 (empagliflozin), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search empagliflozin products by name

Empagliflozin · ATC A10BK03

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of empagliflozin costs, country by country.

Normalised to the WHO defined daily dose (17.5 mg), so markets compare like for like.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Empagliflozin · price per daily dose (17.5 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.80
  • IT Italy$2.95
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Empagliflozinum
Manufacturer
Boehringer Ingelheim International GmbH
Country
Poland (PL)
ATC code
A10BK03
ATC class
Empagliflozin
Defined daily dose
17.5 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 9

2 priced
  • gtin
    05909991138509
    28 szt.
    PLN 144.93
  • gtin
    05909991138523
    60 szt.
    PLN 302.4
  • gtin
    05909991138516
  • gtin
    05909991138493
  • gtin
    05909991138486
  • gtin
    05909991138547
  • gtin
    05909991138479
  • gtin
    05909991138554
  • gtin
    05909991138530

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

466 interactions on record for empagliflozin.

Graded by severity as the source publishes them — 1 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check empagliflozin against other medicinesHow interaction checks work

Empagliflozin · interactions on record

466 records

  • 1 severe
  • 425 moderate
  • 40 minor

Most severe, free to view

  • SucralfateA02BX02moderate
  • PapaverineA03AD01moderate
  • ThiethylperazinA04AB03moderate
  • TriflupromazinA04AD06moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Empagliflozin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All empagliflozin products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Empagliflozin Denk, Empagliflozin Devatis
  • Belgium · Empagliflozin Ab, Empagliflozine Hcs
  • Bulgaria · Глузод, Емлигекса
  • Cyprus · Glusod
  • Czechia · Empagliflozin Polpharma, Empelic
  • Germany · Empagliflozin Devatis, Emprables
  • Denmark · Bifoglan, Elemio
  • Estonia · Glusod
  • Spain · Empagliflozina Aurovitas, Empagliflozina Kern Pharma
  • Finland · Empagliflozin Devatis, Empagliflozin Reddy
  • United Kingdom (Northern Ireland) · Empagliflozin, Empagliflozin G.L. Pharma
  • Greece · Elemio, Empagliflozin Pharmapath
  • Croatia · Glusod
  • Hungary · Empagliflozin Polpharma
  • Ireland · Empagliflozin Krka
  • Iceland · Empagliflozin Reddy, Empagliflozin Wh 10 Mg
  • Liechtenstein · Jardiance
  • Lithuania · Embeflyx, Emlygexa
  • Luxembourg · Empagliflozin Ab
  • Latvia · Embeflyx, Emlygexa
  • Malta · Empagliflozin Denk, Eprekavor
  • Netherlands · Empagliflozine Devatis, Empagliflozine Doc
  • Norway · Empagliflozin Devatis, Empagliflozin Reddy
  • Portugal · Empagliflozina Aurobindo, Empagliflozina Aurovitas
  • Romania · Glusod
  • Sweden · Empagliflozin Devatis, Empagliflozin Labiana
  • Slovenia · Empagliflozin Krka, Glusod
  • Slovakia · Empagliflozin Polpharma, Glusod

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e559671e-4f78-4736-ba6a-e8e4395a823b
GET /v1/drugs/e559671e-4f78-4736-ba6a-e8e4395a823b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909991138523 ¦ Rp ¦ EU/1/14/930/015 ¦ 91414\n60 tabl.\n05909991138516 ¦ Rp ¦ EU/1/14/930/014 ¦ 91415\n30 tabl.\n05909991138493 ¦ Rp ¦ EU/1/14/930/012 ¦ 91416\n14 tabl.\n05909991138509 ¦ Rp ¦ EU/1/14/930/013 ¦ 91417\n28 tabl.\n05909991138486 ¦ Rp ¦ EU/1/14/930/011 ¦ 91418\n10 tabl.\n05909991138547 ¦ Rp ¦ EU/1/14/930/017 ¦ 91419\n90 tabl.\n05909991138479 ¦ Rp ¦ EU/1/14/930/010 ¦ 91420\n7 tabl.\n05909991138554 ¦ Rp ¦ EU/1/14/930/018 ¦ 91421\n100 tabl.\n05909991138530 ¦ Rp ¦ EU/1/14/930/016 ¦ 91422\n70 tabl.",
  "substance": "Empagliflozinum 10 mg",
  "common_name": "Empagliflozinum",
  "pl_product_id": "100315982",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about empagliflozin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console